Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo

Neuroendocrinology Letters

Volumn 22, Issue 2, 2001, Pages 101-108

  Ortiz, G G ^a   Elena Crespo Lopez M ^a   Moran Moguel C ^a   Garcia J J ^a   Reiter, R J ^a   Acuna Castroviejo D ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Apoptosis; DNA fragmentation; Melatonin; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DNA FRAGMENT; FREE RADICAL; MELATONIN; NEUROTOXIN; SCAVENGER;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BRAIN NERVE CELL; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; HISTOPATHOLOGY; IN VIVO STUDY; INJECTION; MALE; MESENCEPHALON; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PREVENTION; PROTECTION; TIME;

EID: 0035032635     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis
2. Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropiridine induce apoptosis of PC12 cells
3. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: Implications for Parkinson's disease
4. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
5. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
6. Increased nigral iron content in postmortem Parkinsonian brain
7. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
8. Oxygen toxicity protecting enzymes in Parkinson's disease
9. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
10. New actions of melatonin on tumor metabolism and growth
11. The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances
12. Melatonin: A potent, endogenous hydroxyl radical scavenger
13. Oxidative damage in the central nervous system: Protection by melatonin
14. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats
15. The oxidant/antioxidant network: Role of melatonin
16. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress
17. A fast method for high-quality genomic DNA extraction from whole human blood
18. The p53 tumor suppressor gene
19. p53 mutations in human cancer
20. Programmed cell death-Many questions still to be answered
21. Apoptosis and diseases
22. Cell death and the cell cycle: A relationship between transformation and neurodegeneration?
23. The toxicity of 6-hydroxydopamine on PC12 and P19 cells
24. Animal models of Parkinsonism using selective neurotoxins: Clinical and basic implications
25. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
26. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
27. The mesolimbic dopaminergic pathway is more resistant then the nigrostriatal dopaminergic pathway to MPTP and MPP toxicity: Role of BDNF gene expression
28. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse
29. Protection from oxidation enhances the survival of cultured mesencephalic neurons
30. Suppression of hydroxyl radical formation by MAO inhibitors: A novel possible neuroprotective mechanism in dopaminergic neurotoxicity
31. Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain
32. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease
33. Protection of substantia nigra from MPP neurotoxicity by N-methyl-D-aspartate antagonists
34. Cell protective role of melatonin in the brain
35. Nitric oxide and apoptosis
36. Possible involvement of caspase in nitric oxide- induced neuronal apoptosis in SH-SY5Y cells
37. Generation of reactive oxygen species, release of L-glutamate and activation of caspasese are required for oxygen-induced apoptosis of embryonic hippocampal neurons in culture
38. Nitric oxide as a bifunctional regulator of apoptosis
39. Melatonin, a highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole assessed in vivo
40. A review of the evidence supporting melatonin as antioxidant
41. Melatonin is protective against MPTP-induced striatal and hippocampal lesions
42. Melatonin and its precursor scavenge nitric oxide
43. Nitrosation of melatonin by nitric oxide and peroxynitrate
44. Distribution of melatonin in mammalian tissues: The relative importance of cytosolic versus nuclear localization
45. Potent protective effct of melatonin on in vivo paraquat-induced oxidative damage in rats
46. Melatonin and protection from genetic damage in blood and bone marrow. Whole body irradiation studies in mice
47. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats
48. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin
49. Melatonin reduces nitric oxide synthase activity in rat hypothalamus
50. Modulation of rat striatal glutamatergic response in search for new neuroprotective agents: Evaluation of melatonin and some kynurenine derivatives
51. Melatonin: Lowering the high price of free radicals
52. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo
53. Protective effect of melatonin against 1-methyl-4-phenylpyridinium inhibition of complex 1 of the mitochondrial respiratory chain
54. Melatonin, mitochondria and bioenergetics
55. Actions of melatonin in the reduction of oxidative stress